For decades, women have been told their pain is often psychological, a perception that has led to underdiagnosis and undertreatment of chronic pain conditions. Now, a growing body of research is confirming what many women have long suspected: their experience of chronic pain is often biologically distinct – and more intense – than that of men. A new study, published in the journal Science Immunology, sheds light on the immunological factors contributing to this disparity, while separate research from Japan highlights the increased mortality risk associated with chronic pain in women.
The study published Friday details how differences in the immune system may explain why women experience exacerbated chronic pain compared to men. Lead author Geoffroy Laumet stated, “The pain of women has been overlooked in clinical practice,” adding that it has often been dismissed as “more in the mind, or that it’s because women are softer and more emotional.” This research challenges those long-held biases, pointing to concrete biological mechanisms at play. The findings suggest that immune cells, specifically microglia, behave differently in males and females, influencing pain perception and persistence.
This isn’t an isolated finding. Research published earlier this year in the journal Science Immunology, and reported by the Japan Times, further supports the idea that women’s pain is not simply a matter of perception. The study underscores the need for a more nuanced understanding of pain pathways and tailored treatment approaches.
Chronic Pain and Mortality Risk in Japanese Women
Compounding the issue of underdiagnosis and undertreatment, new data from Japan reveals a concerning link between chronic pain and increased mortality risk, particularly among women. A longitudinal study conducted as part of the Shika Study, and published in PubMed, followed 2,849 participants aged 40 and older for an extended period. The research found that women with chronic headache and neck/shoulder/elbow/hand pain had significantly higher mortality rates compared to those without these conditions.
Specifically, the study showed that among women, the mortality rate was 9.10% for those with chronic headaches (compared to 1.40% for those without) and 31.80% for those with neck/shoulder/elbow/hand pain (compared to 15.50% for those without). The odds of mortality associated with chronic headache were 9.238 (95% CI 1.729-49.352; P = 0.009), and the adjusted odds ratio for neck/shoulder/elbow/hand pain was 2.586 (95% CI 1.012-6.608; P = 0.047) – but only in women aged 74 years and younger. No statistically significant association was found in men.
The Shika Study’s findings suggest that chronic pain isn’t just a debilitating condition, but a potential indicator of underlying health vulnerabilities in women. The study’s authors emphasize the public health importance of addressing chronic pain in this demographic.
Understanding the Disparities
The reasons for these sex-based differences in both pain experience and mortality risk are complex and multifaceted. The recent research in Science Immunology points to the role of the immune system, but hormonal fluctuations, genetic predispositions, and psychosocial factors also likely contribute. The Japanese study, while not exploring the mechanisms directly, highlights the clinical consequences of these disparities.
The study in Japan included 2849 participants, with 44.75% being male and 55.25% female. The baseline mean age was 64.00 ± 12.21 years for men and 65.44 ± 13.12 years for women. Researchers assessed chronic pain alongside factors like age, sex, smoking habits, and pre-existing conditions such as hypertension, hyperlipidemia, and diabetes mellitus.
Implications for Diagnosis and Treatment
These findings have significant implications for how chronic pain is diagnosed and treated. The traditional “one-size-fits-all” approach is clearly inadequate, given the biological differences between men and women. A more personalized approach, taking into account immunological and hormonal factors, is needed.
the increased mortality risk observed in Japanese women with chronic pain underscores the importance of proactive pain management. Early intervention, comprehensive assessment, and multidisciplinary treatment plans – including physical therapy, psychological support, and pharmacological interventions – may help mitigate both the pain itself and its potential long-term consequences.
The research also calls for a shift in attitudes towards women’s pain. Dismissing or minimizing women’s pain experiences can delay diagnosis and treatment, ultimately leading to poorer outcomes. Healthcare providers need to be educated about the biological basis of sex differences in pain and encouraged to listen to their patients’ concerns.
The next step in this research will likely involve larger, more diverse studies to confirm these findings and further elucidate the underlying mechanisms. Researchers are also exploring novel therapeutic targets based on the immunological pathways identified in the Science Immunology study. For now, the message is clear: women’s pain is real, it’s often different, and it deserves to be taken seriously.
Do you have experience with chronic pain? Share your story in the comments below, and please share this article with anyone who might find it helpful.
